Related Business Topics
Latest Headlines
Reuters - Nov. 19, 2009, 9:04 AM
Markets: Central Nervous System Therapeutics A Comprehensive World Market Review of Geographic Coverage and Vertical Market Analysis Reuters adsrc 'reuters.com.dart/bizfinance/stocks/pressrelease/article;' ( typeof(AD_TRACKER) 'undefined' ...
Forbes.com - Nov. 17, 2009, 9:55 AM
Nov 17 (Reuters) - Leerink Swann upgraded Alkermes Inc to 'outperform' from 'market perform,' a day after the biotechnology firm said its alcohol dependence drug Vivitrol met the main goal of a late-stage study for the treatment of opioid dependence. ...
Reuters - Nov. 17, 2009, 7:06 AM
- Company Continues to Advance Clinical Pipeline - CAMBRIDGE, Mass.--(Business Wire)-- Alkermes, Inc. (NASDAQ: ALKS) today announced the initiation of a phase 2 clinical study of ALKS 33, an investigational oral opioid modulator for the potential ...
Forbes.com - Nov. 16, 2009, 8:44 AM
Stocks on the move Real-time Equity news U.S. stock market report 1043 EST 16Nov2009-RF Micro rises after free cash flow outlook ------------------------------------------------------------------------------ Shares of RF Micro Devices rose on Monday, ...
Forbes.com - Nov. 16, 2009, 8:43 AM
, 11:14 AM EST Stocks on the move Real-time Equity news U.S. stock market report 1052 EST 16Nov2009-Deutsche Bank upgrades three dry bulk shippers ------------------------------------------------------------------------------ Deutsche Bank on Monday ...
Forbes.com - Nov. 16, 2009, 8:07 AM
, 10:41 AM EST Stocks on the move Real-time Equity news U.S. stock market report 1021 EST 16Nov2009-Motorola to buy BitBand for undisclosed amount ------------------------------------------------------------------------------ Motorola Inc said on Monday ...
Forbes.com - Nov. 16, 2009, 8:06 AM
, 10:35 AM EST Stocks on the move Real-time Equity news U.S. stock market report 1017 ET 16Nove2009-American Dairy hammered as revenue outlook cut ------------------------------------------------------------------------------ Shares of American Dairy Inc ...
Forbes.com - Nov. 16, 2009, 7:54 AM
Stocks on the move Real-time Equity news U.S. stock market report 1007 EST 16Nov2009-Lowe's rises after Q3 results, outlook ------------------------------------------------------------------------------ Shares of Lowe's Cos Inc rose in early trading on ...
Forbes.com - Nov. 16, 2009, 7:26 AM
, 10:05 AM EST Stocks on the move Real-time Equity news U.S. stock market report 0947 EST 16Nov2009-Alkermes shares rise after comments on drug trial ------------------------------------------------------------------------------ Shares of Alkermes Inc ...
Forbes.com - Nov. 16, 2009, 7:14 AM
Nov 16 (Reuters) - Alkermes Inc: * Announces positive results from phase 3 clinical study of naltrexone for extended-release injectable suspension for the treatment of opioid dependence * Says to file for FDA approval in the first half of calendar 2010 ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
Alkermes
Develops and markets drug delivery systems including injectable sustained-release and bioabsorbable polymer systems.
www.alkermes.com
Develops and markets drug delivery systems including injectable sustained-release and bioabsorbable polymer systems.
www.alkermes.com
